X
¿¬±¸ºÐ¾ß
³í¹®
Antiviral Activity Against SARS-CoV-2 Variants Using in Silico and in Vitro Approaches
Writer : KR BIOTECH(krbiosun@gmail.com) Date : 2024-03-15 Hits : 26  
Fime :
Antiviral Activity Against SARS-CoV-2 Variants Using in Silico and in Vitro Approaches

J Microbiol
Prev. The N-terminal peptide of the main protease of SARS-CoV-2, targeting dimer interface, inhibits its p
Next Bioactive peptides for boosting stem cell culture platform: Methods and applications